Applied Genetic Technologies (AGTC) Tops Q1 EPS by 1c

Applied Genetic Technologies (NASDAQ: AGTC) reported Q1 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $10.3 million, versus $8.44 million reported last year.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c